← Leaderboards
Nilay D Shah
Mayo Clinic Rochester
$3,252,757
Attributed
$5,207,511
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $722.5K · FY2008–22$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
AHRQ$5,207,511 · 4
By mechanism
K12$2,932,131 · 1
R18$1,884,862 · 1
R21$290,518 · 1
R03$100,000 · 1
Top collaborators
- Timothy Beebe5 shared
- Mark Linzer5 shared
Grant awards (14)
Minnesota Learning Health System Mentored Career Development Program (MN-LHS)$407,797
K12 · FY2022 · HS
Minnesota Learning Health System Mentored Career Development Program (MN-LHS)$722,480
K12 · FY2021 · HS
Minnesota Learning Health System Mentored Career Development Program (MN-LHS)$722,480
K12 · FY2020 · HS
Minnesota Learning Health System Mentored Career Development Program (MN-LHS)$668,535
K12 · FY2019 · HS
Minnesota Learning Health System Mentored Career Development Program (MN-LHS)$410,839
K12 · FY2018 · HS
The ICAN Discussion Aid to Optimize Treatment for People Living with Multiple Chronic Conditions$30,143
R03 · FY2018 · HS · contact PI
The ICAN Discussion Aid to Optimize Treatment for People Living with Multiple Chronic Conditions$69,857
R03 · FY2017 · HS · contact PI
Translating Information on Comparative Effectiveness into Practice$249,039
R18 · FY2013 · HS · contact PI
Translating Information on Comparative Effectiveness into Practice$384,565
R18 · FY2012 · HS · contact PI
Translating Information on Comparative Effectiveness into Practice$435,353
R18 · FY2011 · HS · contact PI
Translating Information on Comparative Effectiveness into Practice$434,151
R18 · FY2010 · HS · contact PI
Translating Information on Comparative Effectiveness into Practice$381,754
R18 · FY2009 · HS · contact PI
Optimizing the Treatment of Diabetes Patients$139,872
R21 · FY2009 · HS · contact PI
Optimizing the Treatment of Diabetes Patients$150,646
R21 · FY2008 · HS · contact PI